SY-3505
Showing 1 - 25 of 44
Advanced Solid Tumor Trial in Beijing (SY-3505)
Recruiting
- Advanced Solid Tumor
- SY-3505
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Sep 15, 2023
Non-small-cell Lung Carcinoma Trial in Beijing (SY-3505)
Recruiting
- Non-small-cell Lung Carcinoma
- SY-3505
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 11, 2023
NSCLC Trial in Beijing (SY-3505)
Recruiting
- Non-small Cell Lung Cancer
- SY-3505
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Mar 17, 2022
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- SY-1425 (tamibarotene)
- +2 more
-
Hartford, Connecticut
- +25 more
May 4, 2022
NSCLC Trial in Shanghai (SY-5007)
Recruiting
- Non-Small Cell Lung Cancer
-
Shanghai, Shanghai, ChinaShanghai Pulmonary Hospital
Sep 4, 2023
Sepsis Trial in Nanjing (SY-005, Placebo)
Recruiting
- Sepsis
- SY-005
- Placebo
-
Nanjing, Jiangsu, ChinaZhongda Hospital,Affiliated to Southeast University
Feb 27, 2022
Gut Microbiome in ADT Related Metabolic Changes in Prostate
Recruiting
- Prostate Cancer
-
Shatin, Hong KongPrince of Wales Hospital
Mar 9, 2022
Effect of ADT in Prostate Cancer Asia (READT Asia Study)
Recruiting
- Prostate Cancer
- Androgen deprivation therapy - bilateral orchidectomy
- +2 more
-
Shatin, Hong KongPrince of Wales Hospital
Dec 14, 2021
Ureteric Stone Trial in Sheung Shui (Ureteroscopic lithotripsy)
Recruiting
- Ureteric Stone
- Ureteroscopic lithotripsy
-
Sheung Shui, Hong KongNorth District Hospital
Jun 27, 2022
Urolithiasis Trial in Shatin
Recruiting
- Urolithiasis
-
Shatin, Hong KongPrince of Wales Hospital
Jun 27, 2022
Acute Promyelocytic Leukemia Trial in United States (SY-2101, Arsenic Trioxide)
Recruiting
- Acute Promyelocytic Leukemia
- SY-2101
- Arsenic Trioxide
-
Birmingham, Alabama
- +4 more
Jul 12, 2022
MRI Prostate in Different Prostate Health Index (Phi) Values
Recruiting
- Prostate Cancer
-
Hong Kong, Hong KongPrince of Wales Hospital, Chinese University of Hong Kong
Jun 29, 2022
Type 2 Diabetes Trial in China (SY-009 capsules)
Not yet recruiting
- Type 2 Diabetes
- SY-009 capsules
-
Bengbu, Anhui, China
- +6 more
Jun 17, 2022
Type 2 Diabetes Trial in Nanjing (SY-008, SY-008 matching )
Completed
- Type 2 Diabetes Mellitus
- SY-008
- SY-008 matching placebo
-
Nanjing, Jiangsu, ChinaNanjing Gulou Hospital
May 17, 2022
Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution
Recruiting
- Dry Eye Disease
- SY-201 Ophthalmic Solution 2.0%
- +3 more
-
Durham, North CarolinaLexitas
Jul 27, 2022
Type 2 Diabetes Trial in China (SY-009, SY-009 matching )
Completed
- Type 2 Diabetes Mellitus
- SY-009
- SY-009 matching placebo
-
Hefei, Anhui, China
- +3 more
Mar 21, 2022
Advanced Solid Tumor Trial in Shanghai (SY-4835)
Recruiting
- Advanced Solid Tumor
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Mar 11, 2022
Prostate Cancer Trial in Hong Kong (MRI and MRI-guided prostate biopsy, TP-arm Systematic biopsy)
Recruiting
- Prostate Cancer
- MRI and MRI-guided prostate biopsy
- TP-arm Systematic biopsy
-
Hong Kong, Hong Kong
- +7 more
Jun 22, 2022
Sarcopenia Trial in Hong Kong (dietary supplement, device, behavioral)
Recruiting
- Sarcopenia
- Hydroxymethylbutyrate
- +2 more
-
Hong Kong, Hong KongEvangelical Luthera Church Social Service - Hong Kong
Mar 8, 2022
NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
-
Shanghai, Shanghai, China
- +1 more
Mar 17, 2022
Prostate Hyperplasia Trial in Hong Kong (3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH)
Not yet recruiting
- Prostate Hyperplasia
- 3D-Ultrasound-Guided Transperineal Microwave needle ablation of BPH
-
Hong Kong, Hong KongPrince of Wales Hospital
Jun 30, 2022
COVID-19 Trial in Beijing, Hong Kong, Torrejón De Ardoz (Non Intervention)
Recruiting
- COVID-19
- Non Intervention
-
Beijing, Beijing, China
- +9 more
Jan 25, 2021